You are here

Takeda

After two Big Pharma deals, Nimbus looks to keep the hits coming

Pharma Voice

Mon, 06/3/24 - 12:01 pm

Nimbus Therapeutics

Gilead Sciences

ASCO: GSK builds case for return of multiple myeloma drug Blenrep

BioPharma Dive

Sun, 06/2/24 - 02:45 pm

mutliple myeloma

Takeda, amid restructuring campaign, plots 641 layoffs at two Massachusetts sites

Fierce Pharma

Tue, 05/28/24 - 10:28 pm

Takeda joins hot molecular glue market with $1.2B deal

BioSpace

Thu, 05/23/24 - 11:59 am

Degron Therapeutics

Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot

Pharmaphorum

Mon, 05/13/24 - 11:13 am

Alzheimer's disease

Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024

BioSpace

Thu, 05/9/24 - 11:38 am

Takeda Pharma to restructure after annual profit slump

Reuters

Thu, 05/9/24 - 11:14 am

A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach

BioSpace

Tue, 04/30/24 - 09:10 am

colorectal cancer

Annette Montandon

Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB

Fierce Pharma

Fri, 04/26/24 - 11:44 am

Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail

Fierce Biotech

Tue, 04/23/24 - 09:42 pm

Neurocrine Biosciences

clinical trials

major depressive disorder

Pharmas form joint venture to jumpstart Japanese drug research

BioPharma Dive

Mon, 04/22/24 - 11:29 am

Sumitomo Mitsui Banking

Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program

Fierce Biotech

Tue, 04/16/24 - 10:10 pm

Kumquat Biosciences

immuno-oncology

Top five biopharma companies hiring in San Diego

BioSpace

Thu, 04/11/24 - 10:55 am

Avidity Biosciences

Element Biosciences

Fate Therapeutics

Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS

Pharma Voice

Wed, 03/27/24 - 10:56 am

cliincal trials

Bristol Myers Squibb

clinical trial diversity

Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice

Fierce Pharma

Tue, 03/26/24 - 04:26 pm

Bristol Myers Squibb

FDA Approves Iclusig for New Patients with Aggressive Leukemia

Managed Healthcare Executive

Tue, 03/19/24 - 09:20 pm

acute lymphoblastic leukemia

Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment

Clinical Trials Arena

Thu, 02/29/24 - 11:11 am

eosinophilic esophagitis

FDA approves Takeda's therapy for allergic inflammation in esophagus

Reuters

Mon, 02/12/24 - 10:21 am

eosinophilic esophagitis

Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another

BioSpace

Fri, 02/9/24 - 11:18 am

clinical trials

Sanofi, Takeda announce CFO changes as part of earnings releases

Medical Marketing and Media

Fri, 02/2/24 - 11:48 am

Pages